Blood test study for early multiple myeloma detection
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This trial is testing a new type of blood test (called a liquid biopsy) to find multiple myeloma early by looking at tiny pieces of DNA in your blood. It is for people already diagnosed with multiple myeloma, smoldering multiple myeloma, or MGUS.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years or older.
- You have been diagnosed with multiple myeloma, smoldering multiple myeloma, or MGUS.
- You are not pregnant or breastfeeding.
- You have not had any other cancer or cancer treatment in the last 5 years.
- You have never had an organ, bone marrow, or stem cell transplant.
- You have not had a blood transfusion in the last 7 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced genetic testing to see if they can predict how monoclonal gammopathies (early blood conditions that may turn into cancer) will change over time. It may help doctors understand your risk better.
This study is collecting blood samples from people with plasma cell disorders to help researchers learn more about these conditions. It may be a good fit if you haven't started treatment yet and are willing to donate samples.
This study looks at “biomarkers,” or measurable signals in blood, in people with multiple myeloma who are being treated for the first time. It may help researchers understand the disease better and how it responds to treatment.
This trial studies myeloma (and closely related blood disorders) by using extra blood or bone marrow samples for lab research. It aims to help discover new ways to understand or treat myeloma.
This study looks at two different “precursor” conditions that can happen before multiple myeloma: MGUS and smoldering myeloma (SMM). Researchers want to better tell which cases are more likely to progress, using blood/urine tests and sometimes bone marrow tissue.
This trial screens first-degree relatives of people with multiple myeloma to check for early signs of the disease before symptoms. It may help doctors understand risk in families and find problems sooner if they occur.
Hear when a new MGUS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.